Los puntos clave no están disponibles para este artículo en este momento.
Patients with lichen planus (LP) refractory to available therapies often experience a high disease burden, representing a population with a clear unmet need for new treatments.
Building similarity graph...
Analyzing shared references across papers
Loading...
Thierry Passeron
Inserm
Maximilian Reinhardt
Novartis (Switzerland)
Benjamin D. Ehst
Oregon Medical Research Center
British Journal of Dermatology
Inserm
University of California, Davis
Friedrich-Alexander-Universität Erlangen-Nürnberg
Building similarity graph...
Analyzing shared references across papers
Loading...
Passeron et al. (Mon,) studied this question.
synapsesocial.com/papers/68e6a4f8b6db64358762829d — DOI: https://doi.org/10.1093/bjd/ljae181
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: